Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Klea HoldingVMDGF 37 Debt-to-Equity is 0.20 as of Dec. 2025, which is 9% below its 10-year median of 0.22. GuruFocus rates VMDGF with a GF Score™ of 37/100 and a GF Value™ of $0.43. The stock has 2 warning signs investors should review. Among 183 Medical Diagnostics & Research companies, Klea Holding ranks better than 56.83% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Klea Holding's Debt-to-Equity or its related term are showing as below:
VMDGF'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.59 Med: 0.22 Max: 7.67
Current: 0.2
During the past 13 years, the highest Debt-to-Equity Ratio of Klea Holding was 7.67. The lowest was -0.59. And the median was 0.22.
VMDGF's Debt-to-Equity is ranked better than 56.83% of 183
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.32
vs VMDGF: 0.20
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Klea Holding Debt-to-Equity Related Terms
Klea Holding Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Klea Holding's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VMDGF vs TMO, DHR, IDXX: Debt-to-Equity Comparison
For the Diagnostics & Research subindustry, Klea Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klea Holding Debt-to-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Klea Holding's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Klea Holding's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klea Holding (VMDGF) has a Debt-to-Equity of 0.20 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Klea Holding and its competitors. This is near median its historical median of 0.22. According to the industry distribution chart, Klea Holding ranks #79 out of 183 companies in the Medical Diagnostics & Research industry, placing it in the top 43.2%.
Is Klea Holding's Debt-to-Equity too high?
Klea Holding's current Debt-to-Equity of 0.20 is near median its 10-year median of 0.22. The Medical Diagnostics & Research industry median Debt-to-Equity is 0.32. Klea Holding's value of 0.20 is 37.5% below this industry median. Based on the distribution chart, Klea Holding ranks #79 out of 183 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Klea Holding has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Klea Holding's Debt-to-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Klea Holding ranks #79 out of 183 companies for Debt-to-Equity. This puts Klea Holding in the upper half of its industry. The industry median Debt-to-Equity is 0.32. Klea Holding's value of 0.20 is 37.5% below this benchmark. While the company's 10-year median is 0.22 vs. the industry median of 0.32, Klea Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Diagnostics & Research company?
The median Debt-to-Equity among Medical Diagnostics & Research companies is 0.32, based on 183 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klea Holding's current Debt-to-Equity of 0.20 is 37.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Klea Holding and its competitors. For the Medical Diagnostics & Research industry, the median Debt-to-Equity is 0.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klea Holding's current Debt-to-Equity is 0.20, which is near median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klea Holding stock overvalued right now?
Klea Holding (VMDGF) has a current Debt-to-Equity of 0.20. The stock's GF Value™ is $0.43, compared to a current price of $0.20 — trading 53.5% below its estimated fair value. The current Debt-to-Equity is 0.20, which is near median its 10-year median of 0.22 and 37.5% below the Medical Diagnostics & Research industry median of 0.32. Klea Holding's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Klea Holding (VMDGF), the current Debt-to-Equity is 0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Klea Holding (VMDGF) Overvalued in 2026?
Based on GuruFocus' analysis, Klea Holding stock appears to be undervalued.
The current stock price of $0.20 is trading 53.5% below its estimated GF Value™ of $0.43.
Key valuation signals for VMDGF:
Debt-to-Equity: 0.20 (near median its 10-year median of 0.22)
GF Value™: $0.43 vs. price of $0.20 (53.5% below fair value)
Industry Position: 37.5% below the Medical Diagnostics & Research median (#79 of 183)
No single metric tells the full story. See the VMDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
37GF Score
Get the complete analysis for VMDGF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMDGF has been successfully added to your 
